Latest Valuation News

Atturra Limited has acknowledged ongoing preliminary discussions to acquire US-based Kitepipe, a Platinum Boomi Partner, amid market speculation. While talks are incomplete, this move aligns with Atturra’s active M&A strategy.

Imperial Pacific Limited reports a $652,000 net gain for the half year ending December 31, 2024, driven by strong investment performance and an increased dividend, despite ongoing challenges with its Excelsior Capital stake.

Perpetual Resources reports significant assay results confirming ultra-high grade spodumene at its Isabella Lithium Project and initiates metallurgical testing at the Raptor Rare Earth Project, backed by a strategic MOU with Minas Gerais government and a $1 million capital raise.

K-TIG Limited is set to transform its business with a $7–10 million capital raise to acquire US-based Metal Powder Works, issuing performance-based vendor shares that an independent expert deems fair and reasonable.

Pacgold Limited reports promising high-grade gold anomalies from a major aircore drilling campaign at its Alice River Gold Project, alongside strategic board appointments and a successful Share Purchase Plan to fuel further exploration.

Clime Investment Management has reported a return to profitability in the December half, proposing an interim dividend and unveiling strategic initiatives to drive future growth.

African Gold Ltd. has temporarily paused trading of its securities, signaling a potentially significant update on the horizon. Investors await clarity on what this development might mean for the gold miner’s future.

Global Masters Fund Limited's latest quarterly report confirms compliance with all financial obligations and highlights a recent interest rate increase on its convertible notes, supported by a robust loan-to-value ratio.

Arrow Minerals Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could influence its market position.

AMCIL Limited posted a half-year profit of $3.6 million, down 12.6%, yet its portfolio outperformed the S&P/ASX 200 with an 8.7% return. The company declared a steady interim dividend amid cautious market conditions.

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Advance Metals has approved an initial diamond drilling program targeting exceptionally high-grade gold zones at its Myrtleford Project, aiming to unlock significant regional potential following a strategic joint venture acquisition.